These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6208291)

  • 41. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ; Gray JJ
    Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.
    Harmenberg J; Sundqvist VA; Gadler H; Levén B; Brännström G; Wahren B
    Antimicrob Agents Chemother; 1986 Oct; 30(4):570-3. PubMed ID: 3024561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reactivation of herpes simplex virus from latently infected mice after administration of cadmium is mouse-strain-dependent.
    Fawl RL; Gesser RM; Valyi-Nagi T; Fraser NW
    J Gen Virol; 1996 Nov; 77 ( Pt 11)():2781-6. PubMed ID: 8922472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
    Al-Saadi SA; Gross P; Wildy P
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():433-8. PubMed ID: 2828517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus: inhibition of replication by three new drugs.
    Lin JC; Smith MC; Cheng YC; Pagano JS
    Science; 1983 Aug; 221(4610):578-9. PubMed ID: 6306771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet.
    Pelosi E; Hicks KA; Sacks SL; Coen DM
    Adv Exp Med Biol; 1992; 312():151-8. PubMed ID: 1325102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia.
    Devi-Rao GB; Bloom DC; Stevens JG; Wagner EK
    J Virol; 1994 Mar; 68(3):1271-82. PubMed ID: 8107193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
    Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of DNA synthesis in varicella-zoster virus-infected cells by BV-araU.
    Machida H; Watanabe Y
    Microbiol Immunol; 1991; 35(2):139-45. PubMed ID: 1653394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.
    Harmenberg J; Källander CF; Gronowitz JS
    Arch Virol; 1982; 74(2-3):219-25. PubMed ID: 6299236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nucleoside analogues as antiviral agents.
    de Clercq E
    Acta Microbiol Acad Sci Hung; 1981; 28(3):289-306. PubMed ID: 6272552
    [No Abstract]   [Full Text] [Related]  

  • 55. Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro.
    Baba M; Ito M; Shigeta S; De Clercq E
    Antimicrob Agents Chemother; 1984 Apr; 25(4):515-7. PubMed ID: 6329083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants.
    Katz JP; Bodin ET; Coen DM
    J Virol; 1990 Sep; 64(9):4288-95. PubMed ID: 2166818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reactivation of herpes simplex virus type 1 in cells of latently infected mouse trigeminal ganglia cultured in serum-free medium.
    Kimura S
    Microbiol Immunol; 1996; 40(3):243-6. PubMed ID: 8934680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
    Harmenberg J; Wahren B; Sundqvist VA; Levén B
    J Antimicrob Chemother; 1985 May; 15(5):567-73. PubMed ID: 2989239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia.
    Sawtell NM; Bernstein DI; Stanberry LR
    J Infect Dis; 1999 Sep; 180(3):821-3. PubMed ID: 10438371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.